Dr Matthew Griffin

Clinical oncology


  • Fee assured

Specialises in

  • Brain/CNS
  • Breast

About us

I am one of 5 members of The Nottingham Oncology Group (TNOG) - Experts in Cancer Care, based at The Park Cancer Centre, Nottingham. We offer expertise in treating a wide range of cancers using chemotherapy, targeted therapy, hormone therapy and technical radiotherapy. I treat the full spectrum of brain and central nervous system cancers, head and neck cancers and breast cancer. I have an interest in intensity-modulated radiotherapy (IMRT) and image-guided radiotherapy (IGRT) and routinely use these modalitites in my clinical practice

Areas of interest

Neuro-oncology; head and neck cancer; brain and spinal cord; breast cancer; male breast cancer; primary and secondary tumour sites; technical radiotherapy - IMRT and IGRT, chemotherapy; targeted therapy; hormone therapy; breath hold radiotherapy; craniospinal axis radiotherapy;

Medical secretaries


  • Video and telephone consultations
About us
Our qualifications & training
Our private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • X0003

    Clinical supervision and planning for delivery of chemotherapy cycle 1 - 21 days - (1-5)

  • X6772

    Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)

    BMI The Park Hospital (1-5)

  • X0007

    Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)

    BMI The Park Hospital (1-5)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and these third parties declare it to be correct and compliant with their relevant regulatory bodies' standards and codes of conduct. We're unable to guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use here.